Categories Health Care, Research Summary

Bausch Health Companies Inc. (BHC) stock research summary | Q3 2021

Bausch Health (NYSE: BHC) was negatively impacted by the COVID-19 pandemic as most of its products are dependent on elective medical procedures or patient choices. Sales of its contact lenses dipped amid pandemic-related restrictions as did revenue from medical devices and surgical systems as surgeries and medical procedures were deferred.

The trends have improved since then as restrictions eased and the company is seeing a recovery in its business, which was evident in its third quarter 2021 performance. However, there are still some risks that persist. Take a look at this report to get an idea of the areas where Bausch sees opportunities for growth and which factors are likely to impact its performance in the near term.

The Bausch Health Companies market research report covers key aspects about the firm including company profile, financial highlights and recent key developments. The report is meant as a resource for investors to form a 360 degree understanding about the firm.

Table of Contents

  1. Overview
  2. Financial Highlights
  3. Outlook
  4. SWOT Analysis
  5. Business Segment Analysis
  6. Strategic Drivers
  7. Competitors
  8. Key Stock Holders 

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

VZ Earnings: All you need to know about Verizon’s Q2 2024 earnings results

Verizon Communications Inc. (NYSE: VZ) reported its second quarter 2024 earnings results today. Total operating revenue was $32.8 billion, up 0.6% from the same period last year. Consolidated net income

Important Takeaways from Netflix’s (NFLX) Q2 2024 report

Netflix, Inc. (NASDAQ: NFLX) has expanded its subscriber base consistently in recent years, with growth accelerating after it launched a crackdown on password sharing a year ago. While delivering better-than-expected

American Express (AXP): Main takeaways from the Q2 2024 earnings report

Shares of American Express Company (NYSE: AXP) dropped over 3% on Friday after the company delivered mixed results for the second quarter of 2024. Profits beat expectations while revenue came

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top